微RNA表达:I/R心肌细胞和赛沃氨酸
José Luis Guerrero-Orriach1,2,3, Maria Dolores Carmona-Luque4, Guillermo Quesada Muñoz1,2
1Institute of Biomedical Research in Malaga, 29010 Malaga, Spain.
Biomolecules
|January 8, 2025
概括
赛沃氨酸通过对心脏细胞中的特定微RNAs (miRNAs) 进行上调来增强心脏保护,从而提供对缺血/反损伤的保护作用. 这项研究确定了参与这些有益心脏反应的关键miRNA.
科学领域:
- 心脏病学 心脏病学
- 麻醉学 麻醉学
- 分子生物学分子生物学
背景情况:
- 麻醉药物,特别是黄,在心脏手术中提供临床益处.
- 这些好处涉及微RNA (miRNA) 介导的分子途径.
- 麻醉剂对miRNA表达和心脏保护的影响尚不清楚.
研究的目的:
- 为了研究类麻醉剂如何改变miRNA的表达.
- 为了确定特定的miRNAs负责sevoflurane的心脏保护作用.
- 为了分析由sevoflurane和propofol诱导的miRNA表达的变化.
主要方法:
- 使用人类心脏肌细胞 (HCMs) 的体外缺血/反 (I/R) 模型.
- 四组的比较:对照组,I/R,I/R与普罗波 (I/R-P),I/R与西沃 (I/R-S).
- 通过下一代测序 (NGS) 来量化p53和Akt1细胞因子和miRNA概况.
主要成果:
- 在I/R HCM中暴露于sevoflurane导致较低的p53和较高的Akt-1水平,相比于propofol.
- 在sevoflurane组中,NGS显示hsa-miR-140-5p,hsa-miR-455-5p,hsa-miR-98-5p,hsa-miR-193a-5p和hsa-let-7d-5p的表达显著增加.
- 这些上调的miRNA与心脏功能,亡抑制和心肌保护有关.
结论:
- 塞沃弗兰诱导特定miRNAs的过度表达,从而赋予心脏保护.
- 这些miRNA变化发生在DNA和信号通路水平,包括Akt/ERK.
- 这些发现突显了sevoflurane通过miRNA调节来保护心肌的潜力.
相关概念视频
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...


